Abstract
Background: Follicular thyroid carcinomas are the second most common form of thyroid cancer and are closely associated with RAS mutations.1,2 Whilst still poorly understood, there are several small studies suggesting that thyroid cancers with RAS mutations are associated with a poor prognosis. This study seeks to investigate the prognostic value of RAS positive mutations within FTCs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
